NCT00368550View on ClinicalTrials.gov

Sertraline Pharmacotherapy for Alcoholism Subtypes

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions
Alcoholism
Interventions
DRUG

Sertraline

Sertraline (to a maximum of 200 mg/day) for 14-week treatment period

DRUG

Placebo

Placebo for 14-week treatment period

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

UConn Health

OTHER

NCT00368550 - Sertraline Pharmacotherapy for Alcoholism Subtypes | Biotech Hunter | Biotech Hunter